Preparation and biomedical applications of chitin and chitosan nanofibers

Journal of Biomedical Nanotechnology

Volumn 10, Issue 10, 2014, Pages 2891-2920

  Azuma, Kazuo ^a   Ifuku, Shinsuke ^b   Osaki, Tomohiro ^a   Okamoto, Yoshiharu ^a   Minami, Saburo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Biomedical applications; Chitin; Chitosan; Cosmetics; Drug delivery; Nanofibers; Obesity; Stem cells; Tissue engineering

Indexed keywords

CHITIN; COSMETICS; DRUG DELIVERY; MEDICAL APPLICATIONS; NANOFIBERS; NUTRITION; SHELLFISH; STEM CELLS; TISSUE ENGINEERING;

ANTI-INFLAMMATORIES; BIOMEDICAL APPLICATIONS; CHITOSAN NANOFIBERS; HIGH SPECIFIC SURFACE AREA; OBESITY; STEM CELL TECHNOLOGY; STRUCTURAL COMPONENT; USEFUL PROPERTIES;

CHITOSAN;

CHITIN; CHITOSAN; NANOFIBER;

ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN; MEDICAL TECHNOLOGY; PROCEDURES; STEM CELL; TISSUE ENGINEERING; ULTRASTRUCTURE;

ANIMALS; BIOMEDICAL TECHNOLOGY; CHITIN; CHITOSAN; HUMANS; NANOFIBERS; STEM CELLS; TISSUE ENGINEERING;

EID: 84905647471     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1882     Document Type: Review

References (238)

1. R. A. A. Muzzarelli, Chitin nanostructures in living organisms, Chitin: Formation and Diagenesis, edited by N. Gupta, Springer, Dordrecht (2011), Vol. 34, pp. 1-34.
2. K. Kurita, Controlled functionalization of the polysaccharide chitin. Prog. Polym. Sci. 269, 1921 (2001).
3. M. Rinaudo, Chitin and chitosan: Properties and applications. Prog. Polym. Sci. 31, 603 (2006).
4. K. S. Pillai, W. Paul, and C. P. Sharma, Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog. Polym. Sci. 34, 641 (2009).
5. R. Jayakumar, M. Prabaharan, S. V. Nair, and H. Tamura, Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol. Adv. 28, 142 (2010).
6. R. Jayakumar, M. Prabaharan, P.T. Sudheesh Kumar, S.V. Nair, and H. Tamura, Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol. Adv. 29, 322 (2011).
7. J. Y. Reginster, A. Neuprez, M. P. Lecart, N. Sarlet, and O. Bruyere, Role of glucosamine in the treatment for osteoarthritis. Rheumatol. Int. 32, 2959 (2012).
8. V. De Silva, A. El-Metwally, E. Ernst, G. Lewith, and G. J. Macfarlane, Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: A systematic review. Rheumatology 50, 911 (2011).
9. J. Y. Je and S. K. Kim, Chitooligosaccharides as potential nutraceuticals: Production and bioactivities. Adv. Food Nutr. Res. 65, 321 (2012).
10. J. Y. Je and S. K. Kim, Chitosan as potential marine nutraceutical. Adv. Food Nutr. Res. 65, 121 (2012).
11. M. Prabaharan and J. F. Mano, Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 12, 41 (2005).
12. R. Jayakumar, K. P. Chennazhi, R. A. A. Muzzarelli, H. Tamura, S. V. Nair, and N. Selvamurugan, Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr. Polym. 79, 1 (2010).
13. R. Jayakumar, M. Prabaharan, R. L. Reis, and J. F. Mano, Graft copolymerized chitosan-Present status and applications. Carbohydr. Polym. 62, 142 (2005).
14. R. Jayakumar, N. Nwe, S. Tokura, and H. Tamura, Sulfated chitin and chitosan as novel biomaterials. Int. J. Biol. Macromol. 40, 175 (2007).
15. R. Jayakumar, Deepthy Menon, K. Manzoor, S. V. Nair, and H. Tamura, Biomedical applications of chitin and chitosan based nanomaterials - A short review. Carbohydr. Polym. 82, 227 (2010).
16. Y. Okamoto, S. Minami, A. Matsuhashi, H. Sashiwa, H. Saimoto, Y. Shigemasa, T. Tanigawa, Y. Tanaka, and S. Tokura, Polymetic N-acetyl-D- glucosamine (Chitin) induces histrionic activation in dogs. J. Vet. Med. Sci. 55, 739 (1993).
17. Y. Okamoto, S. Minami, A. Matsuhashi, H. Sashiwa, H. Saimoto, Y. Shigemasa, T. Tanigawa, Y. Tanaka, and S. Tokura. Application of polymetic N-acetyl-D-glucosamine (Chitin) to veterinary practice. J. Vet. Med. Sci. 55, 743 (1993).
18. A. C. A. Wan and B. C. U. Tai, Chitin - A promising biomaterial for tissue engineering and stem cell technologies. Biotechnol. Adv. 31, 1776 (2013).
19. H. Nagahama, T. Kashiki, N. Nwe, R. Jayakumar, T. Furuike, and H. Tamura, Preparation of biodegradable chitin/gelatin membranes with GlcNAc for tissue engineering applications. Carbohydr. Polym. 73, 456 (2008).
20. H. Nagahama, N. Nwe, R. Jayakumar, S. Koiwa, T. Furuike, and H. Tamura, Novel biodegradable chitin membranes for tissue engineering applications. Carbohydr. Polym. 73, 295 (2008).
21. H. Tamura, T. Furuike, S. V. Nair, and R. Jayakumar, Biomedical applications of chitin hydrogel membranes and scaffolds. Carbohydr. Polym. 84, 820 (2011).
22. N. L. B. M. Yusof, A. Wee, L. Y. Lim, and E. Khor, Flexible chitin films as potential wound-dressing materials: Wound model studies. J. Biomed. Mater. Res. 66A, 224 (2003).
23. P. R. Marreco, P. L. Moreira, S. C. Genari, and A. M. Moraes, Effects of different sterilization methods on the morphology, mechanical properties and cytotoxicity of chitosan membranes used as wound dressings. J. Biomed. Mater. Res. B Appl. Biomater. 71B, 268 (2004).
24. R. Jayakumar, N. Nwe, S. Tokura, and H. Tamura, Sulfated chitin and chitosan as novel biomaterials. Int. J. Biol. Macromol. 40, 175 (2007).
25. R. Jayakumar, N. Nwe, H. Nagahama, and H. Tamura, Synthesis, characterization and biospecific degradation behavior of sulfated chitin. Macromol. Symp. 264, 163 (2008).
26. R. Jayakumara, V. V. Divya Rania, K. T. Shalumona, P. T. Sudheesh Kumara, S. V. Naira, T. Furuike, and H. Tamura, Bioactive and osteoblast cell attachment studies of novel α- and β-chitin membranes for tissue-engineering applications. Int. J. Biol. Macromol. 45, 260 (2009).
27. K. Madhumathia, N. S. Binulala, H. Nagahamab, H. Tamura, K. T. Shalumona, N. Selvamurugana, S. V. Naira, and R. Jayakumara, Preparation and characterization of novel α-chitin-hydroxyapatite composite membranes for tissue engineering applications. Int. J. Biol. Macromol. 44, 1 (2009).
28. K. T. Shalumona, N. S. Binulala, N. Selvamurugana, S. V. Naira, Deepthy Menona, T. Furuike, H. Tamura, and R. Jayakumar, Electrospinning of carboxymethyl chitin/poly(vinyl alcohol) nanofibrous scaffolds for tissue engineering applications. Carbohydr. Polym. 77, 863 (2009).
29. K. T. Shalumon, K. H. Anulekha, C. M. Girish, S. V. Nair, and R. Jayakumar, Single step electrospinning of chitosan/poly(caprolactone) nanofibers using formic acid/acetone solvent mixture. Carbohydr. polym. 80, 413 (2010).
30. N. K. Gopalan and A. Dufresne, Crab shell chitin whisker reinforced natural rubber nanocomposites. 1. Processing and swelling behavior. Biomacromolecules 4, 657 (2003).
31. Y. Fan, T. Saito, and A. Isogai, Preparation of chitin nanofibers from squid pen beta-chitin by simple mechanical treatment under acid conditions. Biomacromolecules 9, 1919 (2008).
32. S. Ifuku, M. Nogi, K. Abe, M. Yoshioka, M. Morimoto, H. Saimoto, and H. Yano, Preparation of chitin nanofibers with a uniform width as alpha-chitin from crab shells. Biomacromolecules 10, 1584 (2009).
33. N. L. B. M. Yusof, L. Y. Lim, and E. Khor, Preparation and characterization of chitin beads as a wound dressing precursor flexible chitin films as potential wound-dressing materials: Wound model studies. J. Biomed. Mater. Res. 54, 59 (2001).
34. R. Jayakumar, R. L. Reis, and J. F. Mano, Phosphorous containing chitosan beads for controlled oral drug delivery. J. Bioact. Compat. Polym. 21, 327-340 (2006).
35. M. Prabaharan, Chitosan derivatives as promising materials for controlled drug delivery. J. Biomater. Appl. 23, 5 (2008).
36. A. Anitha, V. V. Divya Rani, R. Krishna, V. Sreeja, N. Selvamurugan, S. V. Nair, H. Tamura, and R. Jayakumar, Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N,O-carboxymethyl chitosan nanoparticles. Carbohydr. Polym. 78, 672 (2009).
37. A. Anitha, N. Deepa, K. P. Chennazhi, S. V. Nair, H. Tamura, and R. Jayakumar, Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications. Carbohydr. Polym. 83, 66 (2010).
38. M. Peter, P. T. Sudheesh Kumar, N. S. Binulal, S. V. Nair, H. Tamura, and R. Jayakumar, Development of novel chitin/nano bioactive glass ceramic nanocomposite scaffolds for tissue engineering applications. Carbohydr. Polym. 78, 926 (2009).
39. M. Peter, N. S. Binulol, S. Soumya, S. V. Nair, H. Tamura, and R. Jayakumar, Nanocomposite scaffolds of bioactive glass ceramic nanoparticles disseminated chitosan matrix for tissue engineering applications. Carbohydr. Polym. 79, 284 (2010).
40. M. Prabaharan and R. Jayakumar, Chitosan-graft-β-cyclodextrin scaffolds with controlled drug release capability for tissue engineering applications. Int. J. Biol. Macromol. 44, 320 (2009).
41. Y. Maeda, R. Jayakumar, H. Nagahama, T. Furuike, and H. Tamura, Synthesis, characterization and bioactivity studies of novel β-chitin scaffolds for tissue-engineering applications. Int. J. Biol. Macromol. 42, 463-467 (2008).
42. K. Muramatsu, S. Masuda, Y. Yoshihara, and A. Fujisawa, In vitro degradation behavior of freeze-dried carboxymethyl-chitin sponges processed by vacuum-heating and gamma irradiation. Polym. Deg. Stab. 81, 327 (2003).
43. A. Portero, D. Teijeiro-Osorio, M. J. Alonso, and C. Remunan-Lopez, Development of chitosan sponges for buccal administration of insulin. Carbohydr. Polym. 68, 617 (2007).
44. J. Hua, S. Suguro, S. Hirano, K. Sakamoto, and I. Nagaoka, Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm. Res. 54, 127 (2005).
45. I. Nagaoka, M. Igarashi, J. Hua, Y. Ju, S. Yomogida, and K. Sakamoto, Recent aspects of the anti-inflammatory actions of glucosamine. Carbohydr. Polym. 84, 825 (2011).
46. K. Azuma, T. Osaki, T. Wakuda, T. Tsuka, T. Imagawa, Y. Okamoto, and S. Minami, Suppressive effects of N-acetyl-D-glucosamine on rheumatoid arthritis mouse models. Inflammation 35, 1462 (2012).
47. J. Hua, K. Sakamoto, T. Kikukawa, C. Abe, H. Kurosawa, and I. Nagaoka, Evaluation of the suppressive actions of glucosamine on the interleukin-1β- mediated activation of synoviocytes. Inflamm. Res. 56, 432 (2007).
48. S. Yomogida, J. Hua, K. Sakamoto, and I. Nagaoka, Glucosamine suppresses the interleukin-8 production and ICAM-1 expression by TNF-α-stimulated human colonic epithelial cell line HT-29. Int. J. Mol. Med. 22, 205-211 (2008).
49. S. Yomogida, Y. Kojima, Y. Tsutsumi-Ishii, J. Hua, K. Sakamoto, and I. Nagaoka, Glucosamine, a naturally occurring amino monosaccharide, suppresses dextran sulfate sodium-induced colitis in rats. Int. J. Mol. Med. 22, 3217 (2008).
50. Y. Ju, J. Hua, K. Sakamoto, H. Ogawa, and I. Nagaoka, Modulation of TNF-α-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide. Int. J. Mol. Med. 22, 809 (2008).
51. T. S. Vo, D. H. Ngo, Q. V. Ta, I. Wijesekara, C. S. Kong, and S. K. Kim, Protective effect of chitin oligosaccharides against lipopolysaccharide-induced inflammatory response in BV-2 microglia. Cell Immunol. 277, 14 (2012).
52. M. Yousef, R. Pichyangkura, S. Soodvilai, V. Chatsudthipong, and C. Muanprasat, Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action. Pharmacol. Res. 66, 66 (2012).
53. S. Minami, H. Suzuki, Y. Okamoto, T. Fujinaga, and Y. Shigemasa, Chitin and chitosan activate complement via the alternative pathway. Carbohydr. Polym. 36, 115 (1998).
54. Y. Suzuki, Y. Okamoto, M. Morimoto, H. Sashiwa, H. Saimoto, S. Tanioka, Y. Shigemasa, and S. Minami, Influence of physicochemical properties of chitin and chitosan on complement activation. Carbohydr. Polym. 42, 307 (2000).
55. J. F. Revol and R. H. Marchessault, In vitro chiral nematic ordering of chitin crystallites. Int. J. Biol. Macromol. 15, 329 (1993).
56. H. S. Nalwa (ed.), Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology, American Scientific Publishers, Los Angeles, CA (2005), Vols. 1-2.
57. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles, CA (2004/2011), Vols. 1-25.
58. C. Zhang, X. Yuan, L. Wu, Y. Han, and J. Sheng, Study on morphology of electrospun poly(vinyl alcohol) mats. Eur. Polym. J. 41, 423 (2005).
59. Y. Zhang, C. T. Lim, S. Ramakrishna, and Z. M. Huang, Recent development of polymer nanofibers for biomedical and biotechnological applications. J. Mater. Sci. Mater. Med. 16, 933 (2005).
60. J. Fang, H. Niu, T. Lin, and X. Wang, Applications of electrospun nanofibers. Chin. Sci. Bull. 53, 2265 (2008).
61. R. A. A. Muzzarelli, P. Morganti, G. Morganti, P. Palombo, M. Palombo, G. Biagini, M. M. Belmonte, F. Giantomassi, F. Orlandi, and C. Muzzarelli, Chitin nanofibrils/chitosan glycolate composites as wound medicaments. Carbohydr. Polym. 70, 274 (2007).
62. Y. Xia, P. Yang, Y. Sun, Y. Wu, B. Mayers, B. Gates, Y. Yin, F. Kim, and H. Yan, One-dimensional nanostructures: Synthesis, characterization, and applications. Adv. Mater. 15, 353 (2003).
63. D. Li and Y. Xia, Electrospinning of nanofibers: Reinventing the wheel? Adv. Mater. 16, 1151 (2004).
64. Z. M. Huang, Y. Z. Zhang, M. Kotaki, and S. Ramakrishna, A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos. Sci. Technol. 63, 2223 (2003).
65. S. Ramakrishna, K. Fujihara, W. E. Teo, T. Yong, Z. Ma, and R. Ramaseshan, Electrospun nanofibers: Solving global issues. Mater. Today 9, 40 (2006).
66. T. J. Sill and H. A. Recum, Electrospinning: Applications in drug delivery and tissue engineering. Biomaterials 29, 1989 (2008).
67. I. Sakurada, Y. Nukushina, and T. Ito, Experimental determination of the elastic modulus of crystalline regions in oriented polymers. J. Polym. Sci. 57, 651 (1962).
68. D. H. Page and F. Elhosseiny, The mechanical properties of single wood pulp fibers. Part VI. Fibril angle and the shape of the stressstrain curve. J. Pulp Pap. Sci. 84, 99 (1983).
69. T. Nishino, I. Matsuda, and K. Hirao, All-cellulose composite. Macromolecules 37, 7683 (2004).
70. A. F. Turbak, F. W. Synder, and K. R. Sandberg, J. Appl. Polym. Sci.: Appl. Polym. Symp. 37, 815 (1983).
71. T. Taniguchi and K. Okamura, Microfibrillated cellulose, a new cellulose product: Properties, uses, and commercial potential. Polym. Int. 47, 291 (1998).
72. S. Iwamoto, A. N. Nakagaito, H. Yano, and M. Nogi, Optically transparent composites reinforced with plant fiber-based nanofibers. Appl. Phys. A: Mater. Sci. Process 81, 1109 (2005).
73. A. Chakraborty, M. Sain, and M. Kortschot, Cellulose microfibrils: A novel method of preparation using high shear refining and cryocrushing. Holzforschung 59, 102 (2005).
74. A. Bhatnagar and M. Sain, Processing of cellulose nanofiber-reinforced composites. J. Reinf. Plast. Compos. 24, 1259 (2005).
75. H. P. Zhao, X. Q. Feng, and H. Gao, Ultrasonic technique for extracting nanofibers from nature materials. Appl. Phys. Lett. 90, 073112 (2007).
76. K. Abe, S. Iwamoto, and H. Yano, Obtaining cellulose nanofibers with a uniform width of 15 nm from wood. Biomacromolecules 8, 3276 (2007).
77. K. Abe and H. Yano, Comparison of the characteristics of cellulose microfibril aggregates of wood, rice straw and potato tuber. Cellulose 16, 1017 (2009).
78. K. Abe and H. Yano, Comparison of the characteristics of cellulose microfibril aggregates isolated from fiber and parenchyma cells of Moso bamboo (Phyllostachys pubescens). Cellulose 17, 271 (2010).
79. S. Ifuku, M. Adachi, M. Morimoto, and H. Saimoto, Fabrication of cellulose nanofibers from parenchyma cells of pears and apples. Sen'i Gakkaishi 67, 86 (2011).
80. A. Isogai, T. Saito, and H. Fukuzumi, TEMPO-oxidized cellulose nanofibers. Nanoscale 3, 71 (2011).
81. T. Saito, Y. Nishiyama, J. L. Putaux, M. Vignon, and A. Isogai, Homogeneous suspensions of individualized microfibrils from TEMPO-catalyzed oxidation of native cellulose. Biomacromol. 7, 1687 (2006).
82. T. Saito, S. Kimura, Y. Nishiyama, and A. Isogai, A. Cellulose nanofibers prepared by TEMPO-mediated oxidation of native cellulose. Biomacromol. 8, 2485 (2007).
83. T. Saito, M. Hirota, N. Tamura, S. Kimura, H. Fukuzumi, L. Heux, and A. Isogai, Individualization of nano-sized plant cellulose fibrils by direct surface carboxylation using TEMPO catalyst under neutral conditions. Biomacromolecules 10, 1992 (2009).
84. N. K. Gopalan and A. Dufresne, Crab shell chitin whisker reinforced natural rubber nanocomposites. 1. Processing and swelling behavior. Biomacromolecules 4, 657 (2003).
85. D. Raabe, P. Romano, C. Sachs, H. Fabritius, A. Al-Sawalmih, S. B. Yi, G. Servos, and H. G. Hartwig, Microstructure and crystallographic texture of the chitin-protein network in the biological composite material of the exoskeleton of the lobster. Mater. Sci. Eng. A 421, 143 (2006).
86. P. Y. Chen, A. Y. M. Lin, A. J. McKittrick, and M. A. Meyers, Structure and mechanical properties of crab exoskeletons. Acta Biomater. 4, 587 (2008).
87. M. M. Giraud-guille, Fine structure of the chitin-protein system in the crab cuticle. Tissue Cell 16, 75 (1984).
88. D. Raabe, C. Sachs, and P. Romano, The crustacean exoskeleton as an example of a structurally and mechanically graded biological nanocomposite material. Acta Mater. 53, 4281 (2005).
89. J. B. Zeng, Y. S. He, S. L. Li, and Y. Z. Wang, Chitin whiskers: An overview. Biomacromol. 13, 1 (2012).
90. K. Shimahara and Y. Takiguchi, Methods in Enzymology, edited by W. A. Wood and S. T. Kellogg, Academic Press, California (1998), Vol. 161, pp. 417-423.
91. Y. Fan, T. Saito, and A. Isogai, Preparation of chitin nanofibers from squid pen β-Chitin by simple mechanical treatment under acid conditions. Biomacromol. 9, 1919 (2008).
92. R. Minke and J. Blackwell, The structure of alpha-chitin. J. Mol. Biol. 120, 167 (1978).
93. S. Ifuku, M. Nogi, K. Abe, M. Yoshioka, M. Morimoto, H. Saimoto, and H. Yano, Simple preparation method of chitin nanofibers with a uniform width of 10-20 nm from prawn shell under neutral conditions. Carbohyd. Polym. 84, 762-764 (2011).
94. H. Kunzek, S. Müller, S. Vetter, and R. Godeck, The significance of physico chemical properties of plant cell wall materials for the development of innovative food products. Eur. Food Res. Technol. 214, 361 (2002).
95. F. Guillon and M. Champ, Structural and physical properties of dietary fibers, and consequences of processing on human physiology. Food Res. Int. 33, 233 (2000).
96. S. Zivanovic, R. Buescher, and S. K. Kim, Mushroom texture, cell wall composition, color, and ultrastructure as affected by pH and temperature. J. Food Sci. 68, 1860 (2003).
97. S. Ifuku, R Nomura, M. Morimoto, and H. Saimoto, Preparation of chitin nanofibers from mushrooms. Materials 4, 1417 (2011).
98. Y. Fan, T. Saito, and A. Isogai, TEMPO-mediated oxidation of β-chitin to prepare individual nanofibrils. Carbohyd. Polym. 77, 832 (2009).
99. S. Iwamoto, K. Abe, and H. Yano, The effect of hemicelluloses on wood pulp nanofibrillation and nanofiber network characteristics. Biomacromol. 9, 1022 (2008).
100. S. Ifuku, M. Nogi, M. Yoshioka, M. Morimoto, H. Yano, and H. Saimoto, Fibrillation of dried chitin into 10-20 nm nanofibers by a simple grinding method under acidic conditions. Carbohyd. Polym. 81, 134 (2010).
101. Y. Watanabe, S. Kitamura, K. Kawasaki, T. Kato, K. Uegaki, K. Ogura, and K. Ishikawa, Application of a water jet system to the pretreatment of cellulose. Biopolymers 95, 833 (2011).
102. R. Kose and T. Kondo, Favorable 3D-network formation of chitin nanofibers dispersed in water prepared using aqueous counter collision. Sen-I Gakkaishi 67, 91 (2011).
103. S. Ifuku, K. Yamada, M. Morimoto, and H. Saimoto, Nanofibrillation of dry chitin powder by Star Burst system. Journal of Nanomaterials 2012, 1 (2012).
104. A. K. Dutta, K. Yamada, H. Izawa, M. Morimoto, H. Saimoto, and S. Ifuku, Preparation of chitin nanofibers from dry chitin powder by Star Burst system: dependence on number of passes. J. Chitin Chitosan Sci. 1, 59 (2013).
105. R. A. A. Muzzarelli, Chemical and technological advances in chitins and chitosans useful for the formulation of biopharmaceuticals. Chitosan-Based Systems for Biopharmaceuticals, edited by B. Sarmento and J. DasNeves, Wiley, New York (2012), pp. 3-22.
106. R. A. A. Muzzarelli, J. Boudrant, D. Meyer, N. Manno, M. DeMarchis, and M. G. Paoletti, Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science on the chitin bicentennial. Carbohyd. Polym. 87, 995 (2012).
107. R. A. A. Muzzarelli, Nanochitins and nanochitosans, paving the way toeco-friendly and energy-saving exploitation of marine resources. Polymer Science: A Comprehensive Reference, edited by K. Maty-jaszewski and M. Möller, Elsevier, Amsterdam (2012), Vol. 10, pp. 153-164.
108. M. G. Peter, Applications and environmental aspects of chitin and chitosan. Journal of Macromolecular Science, Part A: Pure and Applied Chemistry 32, 629 (1995).
109. S. B. Rao and C. P. Sharma, Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J. Biomedical Mater. Res. 34, 21 (1997).
110. B. Min, S. W. Lee, J. N. Lim, Y. You, T. S. Lee, P. H. Kang, and W. H. Park, Chitin and chitosan nanofibers: Electrospinning of chitin and deacetylation of chitin nanofibers. Polymer 45, 7137 (2004).
111. A. K. Dutta, N. Kawamoto, G. Sugino, H. Izawa, M. Morimoto, H. Saimoto, and S. Ifuku, Simple preparation of chitosan nanofibers from dry chitosan powder by the Star Burst system. Carbohydr. Polym. 97, 363 (2013).
112. S. Ifuku and H. Saimoto, Chitin nanofibers: Preparations, modifications, andapplications. Nanoscale 4, 3308 (2012).
113. T. Elsdale and J. Bard, Collagen substrata for studies on cell behavior. J. Cell Biol. 54, 626 (1972).
114. C. T. Laurencin, A. M. A. Ambrosio, M. D. Borden, and J. A. Cooper, Tissue engineering: Orthopedic applications. Ann. Rev. Biomed. Eng, 1, 19 (1999).
115. A. I. Teixeira, G. A. Abrams, P. J. Bertics, C. J. Murphy, and P. F. Nealey, Epithelial contact guidance on well-defined micro- and nanostructured substrates. J. Cell Sci. 116, 1881 (2003).
116. J. B. Chiu, C. Liu, B. S. Hsiao, B. Chu, and M. Hadjiargyrou, Functionalization of poly(L-lactide)nanofibrous scaffolds with bioactive collagen molecules. J. Biomed. Mater. Res. Part A A83, 1117 (2007).
117. H. K. Noh, S. W. Lee, J. M. Kim, J. E. Oh, K. H. Kim, C. P. Chung, S. C. Choi, W. H. Park, and B. M. Min, Electrospinning of chitin nanofibers: Degradation behavior and cellular response to normal human keratinocytes and fibroblasts. Biomaterials 27, 3934 (2006).
118. K. E. Park, S. Y. Jung, S. J. Lee, B. M. Min, and W. H. Park, Biomimetic nanofibrous scaffolds: preparation and characterization of chitin/silk fibroin blend nanofibers. Int. J. Biol. Macromol. 38, 165 (2006).
119. K. E. Park, H. K. Kang, S. J. Lee, B. M. Min, and W. H. Park, Biomimetic nanofibrous scaffolds: preparation and characterization of PGA/chitin blend nanofibers. Biomacromolecules 7, 635 (2006).
120. N. Bhattarai, D. Edmondson, O. Veiseh, F. A. Matsen, and M. Zhang, Electrospun chitosan-based nanofibers and their cellular compatibility. Biomaterials 26, 6176 (2005).
121. A. Subramanian, D. Vu, G. F. Larsen, and H. Y. Lin, Preparation and evaluation of the electrospun chitosan/PEO fibers for potential applications in cartilage tissue engineering. J. Biomater. Sci. Polym. Ed. 7, 861 (2005).
122. L. Chen, C. Zhu, D. Fan, B. Liu, X. Ma, Z. Duan, and Y. Zhou, A human-like collagen/chitosan electrospun nanofibrous scaffold from aqueous solution: electrospun mechanism and biocompatibility. J. Biomed. Mater. Res. A 99, 395 (2011).
123. H. Peng, Z. Yin, H. Liu, X. Chen, B. Feng, H. Yuan, B. Su, H. Ouyang, and Y. Zhang, Electrospun biomimetic scaffold of hydroxyapatite/chitosan supports enhanced osteogenic differentiation of mMSCs. Nanotechnology 23, 485102 (2012).
124. L. Wright, K. McKeon-Fischer, Z. Cui, L. Nair, and J. Freeman, JPDLA/PLLA and PDLA/PCL nanofibers with a chitosan-based hydrogel in composite scaffolds for tissue engineered cartilage. J. Tissue Eng. Regen. Med. (2012), in press.
125. K. T. Shalumon, S. Sowmya, D. Sathish, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Effect of incorporation of nanoscale bioactive glass and hydroxyapatite in PCL/chitosan nanofibers for bone and periodontal tissue engineering. J. Biomed. Nanotechnol. 9, 430 (2013).
126. X. Mo, Z. Chen, and H. J. Weber, Electrospun nanofibers of collagen-chitosan and P (LLA-CL) for tissue engineering. Frontier. Mater. Sci. 1, 20 (2007).
127. Z. Q. Feng, X. Chu, N. P. Huang, T. Wang, Y. Wang, X. Shi, Y. Ding, and Z. Z. Gu, The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials 30, 2753 (2009).
128. Z. Q. Feng, M. K. Leach, X. H. Chu, Y. C. Wang, T. Tian, X. L. Shi, Y. T. Ding, and Z. Z. Gu, Electrospun chitosan nanofibers for hepatocyte culture. J. Biomed. Nanotechnol. 6, 658 (2010).
129. V. T. Tchemtchoua, G. Atanasova, A. Aqil, P. Filée, N. Garbacki, O. Vanhooteghem, C. Deroanne, A. Noël, C. Jérome, B. Nusgens, Y. Poumay, and A. Colige, Development of a chitosan nanofibrillar scaffold for skin repair and regeneration. Biomacromolecules 12, 3194 (2011).
130. K. T. Shalumon, D. Sathish, S. V. Nair, K. P. Chennazhi, H. Tamura, and R. Jayakumar, Fabrication of aligned poly(lactic acid)-chitosan nanofibers by novel parallel blade collector method for skin tissue engineering. J. Biomed. Nanotechnol. 8, 405 (2012).
131. D. Sundaramurthi, K. S. Vasanthan, P. Kuppan, U. M. Krishnan, and S. Sethuraman, Electrospun nanostructured chitosan-poly(vinyl alcohol) scaffolds: a biomimetic extracellular matrix as dermal substitute. Biomed. Mater. 7, 045005 (2012).
132. H. Y. Lin, H. H. Chen, S. H. Chang, and T. S. Ni, Pectin-chitosan-PVA nanofibrous scaffold made by electrospinning and its potential use as a skin tissue scaffold. J. Biomater. Sci. Polym. Ed. 24, 470 (2013).
133. P. Bruin, M. F. Jonkman, H. J. Meijer, and A. J. Pennings, A new porous polyetherurethane wound covering. J. Biomed. Mater. Res. 24, 217 (1990).
134. K. Matsuda, S. Suzuki, N. Isshiki, K. Yoshioka, R. Wada, T. Okada, and Y. Ikeda, Influence of glycosaminoglycans on the collagen sponges component of a bilayer artificial skin. Biomaterials 11, 351 (1990).
135. S. Suzuki, K. Matsuda, N. Isshiki, Y. Tamada, and Y. Ikada, Experimental study of newly developed bilayer artificial skin. Biomaterials 11, 356 (1990).
136. M. Mattioli-Belmonte, A. Zizzi, G. Lucarini, F. Giantomassi, G. Biagini, G. Tucci F. Orlando, M. Provinciali, F. Carezzi, and P. Morganti, Chitin nanofibrils linked to chitosan glycolate as spray, gel and gauze preparations for wound repair. J. Bioact. Comp. Polym. 22, 525 (2007).
137. A. Chilarski, L. Szosland, I. Krucińska, P. Kiekens, A. Błasińska, G. Schoukens, R. Cisło, and J. Szumilewicz, Novel dressing materials accelerating wound healing made from dibutyrylchitin. Fibers. Tex. Eas. Eur. 15, 77 (2007).
138. A. Blasinska and J. Drobnik, Effects of nonwoven mats of di-O-butyrylchitin and related polymers on the process of wound healing. Biomacroloecules 9, 776 (2008).
139. S. I. Jang, J. Y. Mok, I. H. Jeon, K. H. Park, T. T. Nguyen, J. S. Park, H. M. Hwang, M. S. Song, D. Lee, and K. Y. Chai, Effect of electrospun non-woven mats of dibutyryl chitin/poly(lactic acid) blends on wound healing in hairless mice. Molecules 17, 2992 (2012).
140. T. Tashiro, Antibacterial and bacterium adsorbing macromolecules. Macromol. Mater. Eng. 286, 63 (2001).
141. M. Ignatova, N. Manolova, and I. Rashkov, Novel antibacterial fibers of quaternized chitosan and poly(vinyl pyrrolidine) prepared by electrospinning. Eur. Polym. J. 43, 1112 (2007).
142. M. Ignatova, K. Starbova, N. Markova, N. Manolova, and I. Rashkov, Electrospun nano-fibre mats with antibacterial properties from quaternized chitosan and poly(vinyl alcohol). Carbohydr. Res. 341, 2098 (2006).
143. Y. Zhou, D. Yang, X. Chen, Q. Xu, F. Lu, and J. Nie, Electrospun water-soluble carboxyethyl chitosan/poly(vinyl alcohol) nanofibrous membrane as potential wound dressing for skin regeneration. Biomacromolecules 9, 349 (2008).
144. N. Charernsriwilaiwat, P. Opanasopit, T. Rojanarata, and T. Ngawhirunpat, Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing. Int. J. Pharm. 427, 379 (2012).
145. Y. Zhou, H. Yang, X. Liu, J. Mao, S. Gu, and W. Xu, Electrospinning of carboxyethyl chitosan/poly(vinyl alcohol)/silk fibroin nanoparticles for wound dressings. Int. J. Biol. Macromol. 53, 88 (2013).
146. L. Y. Huang, T. Y. Liu, K. H. Liu, Y. Y. Liu, C. S. Chao, W. L. Tung, and M. C. Yang, Electrospinning of amphipathic chitosan nanofibers for surgical implants application. J. Nanosci. Nanotechnol. 12, 5066 (2012).
147. Y. Li, F. Chen, J. Nie, and D. Yang, Electrospun poly(lactic acid)/chitosan core-shell structure nanofibers from homogeneous solution. Carbohydr. Polym. 90, 1445 (2012).
148. Z. Chen, X. Mo, C. He, and H. Wang, Intermolecular interactions in electrospun collagen-chitosan complex nanofibers. Carbohydr. Polym. 72, 410-418 (2008).
149. X. Wang, C. You, X. Hu, Y. Zheng, Q. Li, Z. Feng, H. Sun, C. Gao, and C. Han, The roles of knitted mesh-reinforced collagen-chitosan hybrid scaffold in the one-step repair of full-thickness skin defects in rats. Acta. Biomater. 9, 7822 (2013).
150. L. Y. Kossovich, Y. Salkovskiy, and I. V. Kirillova, Electrospun chitosan nanofiber materials as burn dressing. IFMBE Proc. 31, 1212 (2010).
151. Z. X. Cai, X. M. Mo, K. H. Zhang, L. P. Fan, A. L. Yin, C. L. He, and H. S. Wang, Fabrication of chitosan/silk fibroin composite nanofibers for wound-dressing applications. Int. J. Mol. Sci. 11, 3529 (2010).
152. A. W. Rawlings and C. R. Harding, Moisturization and skin barrier function. Dermatol. Ther. 17, 43 (2004).
153. E. J. Cler and A. Fourtanier, L'acide pyrrolidone carboxylique (PCA) et la peau. Int. J. of Cosmet. Sci. 3, 101 (1981).
154. T. Tezuka, Electron-microscopic changes in xerosis senilis epidermis. Itsabnormal membrane-coating formation. Dermatologica 166, 57 (1983).
155. M. Denda, J. Sato, Y. Masuda, T. Tsuchiya, J. Koyama, M. Kuramoto, P. M. Elias, and K. P. Feingold, Exposure to a dry environment enhances epidermal permeability barrier function. J. Invest. Dermatol. 111, 858 (1998).
156. A. Kubo, K. Nagao, M. Yokouchi, H. Sasaki, and M. Amagai, External anti-gen uptake by Langerhans cells with reorganization of epidermal tight junctionbarriers. J. Exp. Med. 13, 2937 (2009).
157. P. Morganti, R. A. A. Muzzarelli, and C. Muzzarelli, Multifunctional use of innovative chitin derivatives for skin care. J. Appl. Cosmetol. 24, 105 (2006).
158. P. Morganti and G. Morganti, Chitin nanofibrils for advanced cosmeceuticals. Clin. Dermatol. 26, 334 (2008).
159. I. Ito, T. Osaki, S. Ifuku, H. Saimoto, Y. Takamori, S. Kurozumi, T. Imagawa, K. Azuma, T. Tsuka, Y. Okamoto, and S. Minami, Evaluation of the effects of chitin nanofibrils on skin function using skin models. Carbohydr. Polym. 101, 464 (2014).
160. K. G. Sylvester and M. T. Longaker, Stem cells: Review and update. Arch. Surg. 139, 93 (2004).
161. S. M. Wu and K. Hochedlinger, Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13, 497 (2011).
162. H. F. Lu, K. Narayanan, S. X. Lim, S. Gao, M. F. Leong, and A. C. Wan, A 3D microfibrous scaffold for long-term human pluripotent stem cell self-renewal under chemically defined conditions. Biomaterials 33, 2419 (2012).
163. H. Jang, T. W. Kim, S. Yoon, S. Y. Choi, T. W. Kang, S. Y. Kim, Y. W. Kwon, E. L. J. Chou, and H. D. Youn, O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11, 62 (2012).
164. H. F. Lu, S. X. Lim, M. F. Leong, K. Narayanan, P. Kie, R. Toh, S. Gao, and A. C. A. Wan, Efficient neuronal differentiation and maturation of human pluripotent stem cells encapsulated in 3D microfibrous scaffolds. Biomaterials 33, 9179 (2012).
165. E. K. Yim, A. C. Wan, C. Le Visage, I. C. Liao, and K. W. Leong, Proliferation and differentiation of human mesenchymal stem cell encapsulated in polyelectrolyte complexation fibrous scaffold. Biomaterials 27, 6111 (2006).
166. L. Li, J. H. Hui, J. C. Goh, F. Chen, and E. H. Lee, Chitin as a scaffold for mesenchymal stem cells transfers in the treatment of partial growth arrest. J. Pediatr. Orthop. 24, 205 (2004).
167. I. C. Liao, A. C. Wan, E. K. Yim, and K. W. Leong, Controlled release from fibers of polyelectrolyte complexes. J. Control Release 104, 347 (2005).
168. A. C. Wan, E. K. Yim, I. C. Liao, C. Le Visage, and K. W. Leong, Encapsulation of biologics in self-assembled fibers as biostructural units for tissue engineering. J. Biomed. Mater. Res. A 71, 586 (2004).
169. A. C. Wan, B. C. U. Tai, K. J. Leck, and J. Y. Ying, Silica-incorporated polyelectrolyte-complex fibers as tissue-engineering scaffolds. Adv. Mater. 18, 641 (2006).
170. T. C. Lim, M. F. Leong, H. Lu, C. Du, S. Gao, A. C. Wan, and J. Y. Yong, Follicular dermal papilla structures by organization of epithelial and mesenchymal cells in interfacial polyelectrolyte complex fibers. Biomaterials 34, 7064 (2013).
171. A. C. Wan, M. F. Leong, J. K. C. Toh, Y. Zheng, and J. Y. Ying, Multicomponent fibers by multi-interfacial polyelectrolyte complexation. Adv. Healthc. Mater. 1, 101 (2012).
172. M. G. Ignatova, N. E. Manolova, R. A. Toshkova, I. B. Rashkov, E. G. Gardeva, L. S. Yossifova, and M. T. Alexandrov, Electrospun nanofibrous mats containing quaternized chitosan and polylactide with in vitro antitumor activity against HeLa cells. Biomacromolecules 11, 1633 (2010).
173. R. Toshkova, N. Manolova, E. Gardeva, M. Ignatova, L. Yossifova, I. Rashkov, and M. Alexandrov, Antitumor activity of quaternized chitosan-based electrospun implants against Graffi myeloid tumor. Int. J. Pharm. 400, 221 (2010).
174. M. Ignatova, N. Manolova, R. Toshkova, I. Rashkov, E. Gardeva, I. Yossifova, and M. Alexandrov, Quaternized chitosan-coated nanofibrous materials containing gossypol: Preparation by electrospinning, characterization and
175. T. C. Lin, F. H. Lin, and J. C. Lin, In vitro feasibility study of the use of a magnetic electrospun chitosan nanofiber composite for hyperthermia treatment of tumor cells. Acta. Biomater. 8, 2704 (2012).
176. S. S. Sundar and D. Sangeetha, Fabrication and evaluation of electrospun collagen/poly(N -isopropyl acrylamide)/chitosan mat as blood-contacting biomaterials for drug delivery. J. Mater. Sci. Mater. Med. 23, 1421 (2012).
177. H. Jiang, D. Fang, B. Hsiao, B. Chu, and W. Chen, Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan electrospun membranes. J. Biomater. Sci. Polym. Ed. 15, 279 (2004).
178. Y. Wang, B. Wang, W. Qiao, and T. Yin, A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles. J. Pharm. Sci. 99, 4805 (2010).
179. M. Chen, S. Gao, M. Dong, J. Song, C. Yang, K. A. Howard, J. Kjems, and F. Besenbacher, Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 6, 4835 (2012).
180. G. Morrison, B. Headon, and P. Gibson, Update in inflammatory bowel disease. Aust. Fam. Physician. 38, 956 (2009).
181. S. Melgar, A. Karlsson, and E. Michaëlsson, E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1328 (2005).
182. K. Nakamura, K. Honda, T. Mizutani, H. Akiho, and N. Harada, Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J. Gastroenterol. 12, 4628 (2006).
183. M. J. Carter, A. J. Lobo, and S. P. Travis, Guidelines for the management of inflammatory bowel disease in adults. Gut 53, V1 (2004).
184. G. R. Lichenstein, M. T. Abreu, R. Cohen, and W. Tremaine, American gastroenterological association institute technical review on corticosteroids, immunomodulators and infliximab in inflammatory bowel disease. Gastroenterology 130, 940 (2006).
185. M. Coëffier, R. Marion-Letellier, and P. Déchelotte, Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm. Bow. Dis. 16, 518 (2010).
186. N. Rajendran and D. Kumar, Role of diet in the management of inflammatory bowel disease. World J. Gastroenterol. 16, 1442 (2010).
187. M. E. Rodríguez-Cabezas, J. Gálvez, M. D. Lorente, A. Concha, D. Camuesco, S. Azzouz, A. Osuna, L. Redondo, and A. Zarzuelo, Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J. Nutr. 132, 3263 (2002).
188. C. Vanderpool, F. Yan, and D. B. Polk, Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bow. Dis. 14, 1585 (2008).
189. K. Azuma, T. Osaki, T. Wakuda, S. Ifuku, H. Saimoto, T. Tsuka, T. Imagawa, Y. Okamoto, and S. Minami, Beneficial and preventive effect of chitin nanofibrils in a dextran sulfate sodium-induced acute ulcerative colitis model. Carbohydr. Polym. 87, 1399 (2012).
190. Y. Naito, T. Takagi, and T. Yoshikawa, Neutrophil-dependent oxidative stress in ulcerative colitis. J. Clin. Biochem. Nutr. 41, 18 (2007).
191. R. K. Schindhelm, L. P. van der Zwan, T. Teerlink, and P. G. Scheffer, Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin. Chem. 55, 1462 (2009).
192. J. Mudeter and M. F. Neurath, IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13, 1016 (2007).
193. K. Azuma, T. Osaki, S. Ifuku, H. Saimoto, T. Tsuka, T. Imagawa, Y. Okamoto, and S. Minami, α-Chitin nanofibrils improve inflammatory and fibrosis responses in mice with inflammatory bowel disease. Carbohydr. Polym. 90, 197 (2012).
194. Y. Motomura, W. I. Khan, R. T. El-Sharkawy, M. Verma-Gandhu, E. F. Verdu, J. Gauldie, and S. M. Collins, Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. Gut 55, 662 (2006).
195. C. O. Elson, Y. Cong, V. J. McCracken, R. A. Dimmitt, R. G. Lorenz, and C. T. Weaver, Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206, 260 (2005).
196. T. Zarubin and J. Han, Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11 (2005).
197. W. I. Khan, Y. Motomura, H. Wang, R. T. El-Sharkawy, E. F. Verdu, M. Verma-Gandhu, B. J. Rollins, and S. M. Collins, Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G803 (2006).
198. Y. Ju, J. Hua, K. Sakamoto, H. Ogawa, and I. Nagaoka, Modulation of TNF-alpha-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide. Int. J. Mol. Med. 22, 809 (2008).
199. F. Khoushab and M. Yamabhai, Chitin research revisited. Mar. Drugs 8, 1988 (2010).
200. M. K. Jang, B. G. Kong, Y. I. Jeong, C. H. Lee, and J. W. Nah, Physicochemical characterization of α-chitin, β-chitin, and γ-chitin separated from natural resources. J. Polym. Sci. A Polym. Chem. 42, 3423 (2004).
201. J. Blackwell, Structure of β-chitin or parallel chain systems of poly-β-(1 → 4)-n-acetyl-d -glucosamine. Biopolymers 7, 281 (1969).
202. R. Minke and J. Blackwell, The structure of alpha-chitin. J. Mol. Biol. 120, 167 (1978).
203. K. M. Rudall and W. Kenchington, The chitin system. Biol. Rev. 48, 597 (1973).
204. E. Atkins, Conformations in polysaccharides and complex carbohydrates. J. Biosci. 8, 375 (1985).
205. K. Kurita, K. Sugita, N. Kodaira, M. Hirakawa, and J. Yang, Preparation and evaluation of trimethylsilylated chitin as a versatile precursor for facile chemical modifications. Biomacromolecules 6, 1414 (2005).
206. Y. Saito, J. L. Putaux, T. Okano, F. Gaill, and H. Chanzy, Structural aspects of the swelling of beta-chitin in HCl and its conversion into alpha-chitin. Macromolecules 30, 3867 (1997).
207. P. Sikorski, R. Hori, and M. Wada, Revisit of alpha-chitin crystal structure using high resolution X-ray diffraction data. Biomacromolecules 10, 1100 (2009).
208. K. Azuma, T. Osaki, S. Ifuku, H. Saimoto, T. Tsuka, T. Imagawa, Y. Okamoto, and S. Minami, A comparative study analysis of α-chitin and β-chitin nanofibrils by using an inflammatory-bowel disease mouse model. J. chitin chitosan sci. 1, 144 (2013).
209. I. Vucenik and J. P. Stains, Obesity and cancer risk: Evidence, mechanisms, and recommendations. Ann. N Y Acad. Sci. 1271, 37 (2012).
210. J. Y. Je, P. J. Park, and S. K. Kim, Free radical scavenging properties of hetero-chitooligosaccharides using an ESR spectroscopy. Food Chem. Toxicol. 42, 381 (2004).
211. S. H. Park, B. I. Kim, S. H. Kim, H. J. Kim, D. I. Park, Y. K. Cho, I. K. Sung, C. I. Sohn, H. Kim, D. K. Keum, H. D. Kim, J. H. Park, J. H. Kang, and W. K. Jeon, Body fat distribution and insulin resistance: Beyond obesity in nonalcoholic fatty liver disease among overweight men. J. Am. Coll. Nutr. 26, 321 (2007).
212. I. Grattagliano, V. O. Palmieri, P. Portincasa, A. Moschetta, and G. Palasciano, Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J. Nutr. Biochem. 19, 491 (2008).
213. K. Chen, J. B. Lindsey, A. Khera, J. A. De Lemos, C. R. Ayers, A. Goyal, G. L. Vega, S. A. Murphy, S. M. Grundy, and D. K. McGuire, Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: Observations from the Dallas Heart Study. Diab. Vasc. Dis. Res. 5, 96 (2008).
214. N. Ishizaka, Y. Ishizaka, M. Yamakado, E. Toda, K. Koike, and R. Nagai, Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test. Atherosclerosis 204, 619 (2009).
215. D. W. Haslam and W. P. James, Obesity. Lancet. 366, 1197 (2005).
216. J. D. Browning, L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. C. Cohen, S. M. Grundy, and H. H. Hobbs, Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40, 1387 (2004).
217. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343 (2005).
218. B. Fromenty, M. A. Robin, A. Igoudjil, A. Mansouri, and D. Pessayre, The ins and outs of mitochondrial dysfunction in NASH. Diabetes. Metab. 30, 121 (2004).
219. C. Postic and J. Girard, Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118, 829 (2008).
220. E. Fabbrini, B. S. Mohammed, F. Magkos, K. M. Korenblat, B. W. Patterson, and S. Klein. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424 (2008).
221. F. Thielecke and M. Boschmann, The potential role of green tea catechins in the prevention of the metabolic syndrome - A review. Phytochemistry 70, 11 (2009).
222. J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha, The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 373, 545 (2008).
223. F. R. Seiva, L. G. Chuffa, C. P. Braga, J. P. Amorim, and A. A. Fernandes, Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations. Food Chem. Toxicol. 50, 3726 (2012).
224. O. Y. Kim, S. M. Lee, H. Do, J. Moon, K. H. Lee, Y. J. Cha, and M. J. Shin, Influence of quercetin-rich onion peel extracts on adipokine expression in the visceral adipose tissue of rats. Phytother. Res. 26, 432 (2012).
225. G. R. Kaats, J. E. Michalek, and H. G. Preuss, Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. J. Am. Coll. Nutr. 25, 389 (2006).
226. N. G. Schipper, K. M. Vârum, P. Stenberg, G. Ocklind, H. Lennernäs, and P. Artursson, Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8, 335 (1999).
227. M. Anraku, A. Michihara, T. Yasufuku, K. Akasaki, D. Tsuchiya, H. Nishio, T. Maruyama, M. Otagiri, Y. Maezaki, Y. Kondo, and H. Tomida, The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats. Biol. Pharm. Bull. 33, 1994 (2010).
228. J. E. Pie, J. H. Park, Y. H. Park, Y. M. Ryu, K. N. Kim, S. W. Suh, K. G. Becker, Y. S. Cho-Chung, and M. K. Kim, Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J. Nutr. Biochem. 17, 157 (2006).
229. D. J. Ormrod, C. C. Holmes, and T. E. Miller, Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138, 329 (1998).
230. C. M. Gallaher, J. Munion, R. Hesslink Jr, J. Wise, and D. D. Gallaher, Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr. 130, 2753 (2000).
231. M. Sugano, T. Fujikawa, Y. Hiratsuji, K. Nakashima, N. Fukuda, and Y. Hasegawa, A novel use of chitosan as a hypocholesterolemic agent in rats. Am. J. Clin. Nutr. 33, 787 (1980).
232. M. Fasshauer and R. Paschke, Regulation of adipocytokines and insulin resistance. Diabetologia 46, 1594 (2003).
233. M. Gnacińska, S. Małgorzewicz, M. Stojek, W. ŁysiakSzydłowska, and K. Sworczak, Role of adipokines in complications related to obesity: a review. Adv. Med. Sci. 54, 150 (2009).
234. E. D. Rosen and B. M. Spiegelman, Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847 (2006).
235. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa, Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79 (1999).
236. M. W. Bradbury, Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G194 (2006).
237. H. Doege and A. Stahl, Protein-mediated fatty acid uptake: Novel insights from in vivo models. Physiology (Bethesda) 21, 259 (2006).
238. Y. Kawano and D. E. Cohen, Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 48, 434 (2013).